Abstract

The availability of drugs for international nonproprietary names "Sertraline", "Tianeptin", "Amitriptyline" using an integrated approach was studied. It is substantiated that drugs under international nonproprietary name "Sertraline" are the most accessible for medical staff and affected patients. Particularities of clinical and pharmacological, classification and legal, nomenclature and legal groups of drugs according to international nonproprietary name "Sertraline" were determined. It is noted that the use of drugs under the international nonproprietary name "Sertraline" will comply with the principles of socially oriented pharmacotherapy of mental disorders for the affected contingents of patients in a special period in Ukraine.

Highlights

  • "Amitriptyline" using an integrated approach was studied

  • It is substantiated that drugs under international nonproprietary name "Sertraline" are the most accessible for medical staff and affected patients

  • Particularities of clinical and pharmacological, classification and legal, nomenclature and legal groups of drugs according to international nonproprietary name "Sertraline" were determined

Read more

Summary

Introduction

"Amitriptyline" using an integrated approach was studied. It is substantiated that drugs under international nonproprietary name "Sertraline" are the most accessible for medical staff and affected patients. It is noted that the use of drugs under the international nonproprietary name "Sertraline" will comply with the principles of socially oriented pharmacotherapy of mental disorders for the affected contingents of patients in a special period in Ukraine. Опрацювання доступності для медперсоналу та пацієнтів клініко-фармакологічної групи антидепресантів для фармакотерапії депресивних розладів у постраждалих осіб з використанням комплексного підходу шляхом клініко-фармакологічного, нормативно-правового, документального, маркетингового, соціологічного, статистичного аналізу. В анкети було включено питання щодо використання лікарських засобів (ЛЗ) для фармакотерапії депресивних розладів у пацієнтів (постраждалі особи та їх близькі родичі).

Results
Conclusion
Full Text
Paper version not known

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call

Disclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.